Mesnex

Mesnex is a brand name of mesna, approved by the FDA in the following formulation(s):

MESNEX (mesna - injectable; intravenous)

• 
  Manufacturer: BAXTER HLTHCARE
  
  Approval date: December 30, 1988
  
  Strength(s): 100MG/ML ^[RLD][AP]

MESNEX (mesna - tablet; oral)

• 
  Manufacturer: BAXTER HLTHCARE
  
  Approval date: March 21, 2002
  
  Strength(s): 400MG ^[RLD]

Has a generic version of Mesnex been approved?

A generic version of Mesnex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Mesnex and have been approved by the FDA:

mesna injectable; intravenous

• 
  Manufacturer: APP PHARMS
  
  Approval date: April 26, 2001
  
  Strength(s): 100MG/ML ^[AP]


• 
  Manufacturer: BEDFORD
  
  Approval date: January 9, 2004
  
  Strength(s): 100MG/ML ^[AP]


• 
  Manufacturer: SAGENT STRIDES
  
  Approval date: April 13, 2010
  
  Strength(s): 100MG/ML ^[AP]


• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: April 27, 2001
  
  Strength(s): 100MG/ML ^[AP]

Note: No generic formulation of the following product is available.

• mesna - tablet; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mesnex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Tablets and granulates containing mesna as active substance
  Patent 5,252,341
  Issued: October 12, 1993
  Inventor(s): Sauerbier; Dieter & Engel; Jurgen & Milsmann; Eckhard
  Assignee(s): Degussa Aktiengesellschaft
  A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain 0.01-1 parts by weight of a binding agent 0.03-0.4 parts by weight of a disintegrant 0.01-0.2 parts by weight of a lubricant and 0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
  
  Patent expiration dates:
  
  
  • July 16, 2011
    
  
  



• 
  Tablets and granulates containing mesna as active substance
  Patent 5,262,169
  Issued: November 16, 1993
  Inventor(s): Sauerbier; Dieter & Engel; Jurgen & Milsmann; Eckhard
  Assignee(s): Asta Medica Aktiengesellschaft
  A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain: 0.01-1 parts by weight of a binding agent 0.03-0.4 parts by weight of a disintegrant 0.01-0.2 parts by weight of a lubricant and 0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
  
  Patent expiration dates:
  
  
  • July 16, 2011
    
  
  

See also...

• Mesnex Consumer Information (Wolters Kluwer)
• Mesnex Tablets Consumer Information (Wolters Kluwer)
• Mesnex Consumer Information (Cerner Multum)
• Mesnex Advanced Consumer Information (Micromedex)
• Mesnex AHFS DI Monographs (ASHP)
• Mesna Consumer Information (Wolters Kluwer)
• Mesna Tablets Consumer Information (Wolters Kluwer)
• Mesna Consumer Information (Cerner Multum)
• Mesna Intravenous Advanced Consumer Information (Micromedex)
• Mesna AHFS DI Monographs (ASHP)